On July 15, 2025, Lee Zeldin filed a financial disclosure report highlighting several trades in the stock market. Zeldin executed a series of transactions involving Datavault (DVLT) and NeuroSense Therapeutics Ltd. (NRSN).

Firstly, Zeldin engaged in trading activities with Datavault (DVLT). On May 13, 2025, he purchased shares valued between $1,001 and $15,000. Shortly after, on May 16, 2025, he sold shares of the same company, again in the range of $1,001 to $15,000. This quick turnaround suggests a short-term trading strategy, possibly taking advantage of market fluctuations or specific events affecting the company.

In addition to the DVLT transactions, Zeldin also sold shares of NeuroSense Therapeutics Ltd. (NRSN) on May 13, 2025, with the transaction amount similarly ranging between $1,001 and $15,000. This sale could indicate a strategic decision to reallocate his investment portfolio or a response to market conditions affecting the biotechnology sector.

Overall, these trades reflect active engagement in the stock market by Lee Zeldin, with a focus on both technology and biotech sectors.